Table 3.
Relevant factors influencing the global health status of the breast and cervical cancer survivors according to the multiple regression analysis
| Variable | Breast cancer (N = 252) | Cervical cancer (N = 75) | ||||
|---|---|---|---|---|---|---|
| β | SE | P | β | SE | P | |
| Intercept | 83.8 | 7.04 | <0.001 | 66.45 | 3.83 | <0.001 |
| Monthly household income | ||||||
| ≦US$1,000 (reference) | ||||||
| US$1,001–US$2,000 | 8.75 | 3.37 | 0.010 | 11.72 | 4.91 | 0.017 |
| ≥ US$2,001 | 10.99 | 3.83 | 0.004 | 15.45 | 3.55 | <0.001 |
| Number of comorbidities | ||||||
| 0 (reference) | ||||||
| 1 | −0.61 | 2.69 | 0.820 | |||
| 2 | −7.15 | 3.66 | 0.051 | |||
| ≧3 | −15.27 | 4.94 | 0.002 | |||
| Cancer stage | ||||||
| Stage I (reference) | ||||||
| Stage II | −5.08 | 2.53 | 0.045 | −1.01 | 1.89 | 0.591 |
| Stage III | 3.90 | 4.42 | 0.378 | 8.54 | 4.64 | 0.066 |
| Stage IV | 6.27 | 12.86 | 0.626 | |||
| Cancer recurrence or metastasization | ||||||
| no (reference) | ||||||
| yes | −4.44 | 5.27 | 0.400 | −6.62 | 4.49 | 0.140 |
| Treatment methods | ||||||
| Chemotherapy (reference) | ||||||
| Surgery & chemotherapy | −18.20 | 4.08 | <0.001 | |||
| Surgery & RT & chemotherapy | −24.46 | 5.00 | <0.001 | |||
| Surgery & HT | −25.96 | 6.10 | <0.001 | |||
| Surgery & RT & HT | −20.23 | 3.40 | <0.001 | |||
| Surgery & chemotherapy & HT | −15.37 | 3.16 | <0.001 | |||
| Surgery & RT & chemotherapy & HT | −22.48 | 4.22 | <0.001 | |||
| Surgery & RT & chemotherapy & HT & target treatment | −16.49 | 3.89 | <0.001 | |||
| Others | −20.07 | 5.81 | <0.001 | |||
| Illness duration | ||||||
| ≧2 and <3 years (reference) | ||||||
| ≧3 and <5 years | 9.54 | 3.73 | 0.011 | |||
| ≥ 5 years | 3.76 | 2.78 | 0.176 | |||